Safety and Efficacy of SINOMED SR for Endovascular Treatment of Acute Ischemic Stroke

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 218 participants.

Also called NCT04973332

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 218 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04973332
Other papers using this trial's data
  • Trajectories of stroke severity and functional outcomes after endovascular treatment in ischemic stroke: A post hoc analysis of a randomized controlled trial Clinical neurology and neurosurgery, 2024-04 DOI, PubMed 38507987

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04973332. Randomized; no masking; primary purpose treatment. Start 2021-08-08 (actual); primary completion 2022-04-07 (actual). Results posted on 2026-02-27.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy of SINOMED SR for Endovascular Treatment of Acute Ischemic Stroke
Condition
Ischemic Stroke, Acute
Condition
Brain Diseases
Condition
Cerebrovascular Disorders
Intervention (Device)
Intracranial thrombectomy stent
Lead sponsor
Sinomed Neurovita Technology Inc. (class: industry)
Collaborator
The General Hospital of Eastern Theater Command (class: other)

Record details

Record id
cardio:ct-nct04973332
Content hash
cdea01633d5a8c3f5e4fd6a319eacbbedb21a63ae76c632b7d6b2bd3efd84d4c